These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35571881)

  • 1. Effect of a High Protein, Low Glycemic Index Dietary Intervention on Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial.
    Sun P; Huang L; Shuai P; Wan Z; Liu Y; Xue J; Liu Y
    Front Nutr; 2022; 9():863834. PubMed ID: 35571881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is a Higher Protein-Lower Glycemic Index Diet More Nutritious Than a Conventional Diet? A PREVIEW Sub-study.
    Meroni A; Muirhead RP; Atkinson FS; Fogelholm M; Raben A; Brand-Miller JC
    Front Nutr; 2020; 7():603801. PubMed ID: 33365325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial.
    Wang YY; Tian F; Qian XL; Ying HM; Zhou ZF
    Front Nutr; 2024; 11():1439473. PubMed ID: 39229586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.
    Sacks FM; Carey VJ; Anderson CA; Miller ER; Copeland T; Charleston J; Harshfield BJ; Laranjo N; McCarron P; Swain J; White K; Yee K; Appel LJ
    JAMA; 2014 Dec; 312(23):2531-41. PubMed ID: 25514303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes.
    Kamolvisit S; Chirnaksorn S; Nimitphong H; Sungkanuparph S
    Cureus; 2021 Oct; 13(10):e19046. PubMed ID: 34858740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
    Schwimmer JB; Ugalde-Nicalo P; Welsh JA; Angeles JE; Cordero M; Harlow KE; Alazraki A; Durelle J; Knight-Scott J; Newton KP; Cleeton R; Knott C; Konomi J; Middleton MS; Travers C; Sirlin CB; Hernandez A; Sekkarie A; McCracken C; Vos MB
    JAMA; 2019 Jan; 321(3):256-265. PubMed ID: 30667502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary composition on energy expenditure during weight-loss maintenance.
    Ebbeling CB; Swain JF; Feldman HA; Wong WW; Hachey DL; Garcia-Lago E; Ludwig DS
    JAMA; 2012 Jun; 307(24):2627-34. PubMed ID: 22735432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial.
    Gögebakan O; Kohl A; Osterhoff MA; van Baak MA; Jebb SA; Papadaki A; Martinez JA; Handjieva-Darlenska T; Hlavaty P; Weickert MO; Holst C; Saris WH; Astrup A; Pfeiffer AF;
    Circulation; 2011 Dec; 124(25):2829-38. PubMed ID: 22104550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.
    Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagström H; Stål P
    JHEP Rep; 2021 Jun; 3(3):100256. PubMed ID: 33898960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
    Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
    Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial.
    Rubinstein A; Miranda JJ; Beratarrechea A; Diez-Canseco F; Kanter R; Gutierrez L; Bernabé-Ortiz A; Irazola V; Fernandez A; Letona P; Martínez H; Ramirez-Zea M;
    Lancet Diabetes Endocrinol; 2016 Jan; 4(1):52-63. PubMed ID: 26653067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
    Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial.
    Tay J; Thompson CH; Luscombe-Marsh ND; Wycherley TP; Noakes M; Buckley JD; Wittert GA; Yancy WS; Brinkworth GD
    Diabetes Obes Metab; 2018 Apr; 20(4):858-871. PubMed ID: 29178536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients.
    Nachit M; Lanthier N; Rodriguez J; Neyrinck AM; Cani PD; Bindels LB; Hiel S; Pachikian BD; Trefois P; Thissen JP; Delzenne NM
    JHEP Rep; 2021 Aug; 3(4):100323. PubMed ID: 34355155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
    Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
    Shemirani F; Djafarian K; Fotouhi A; Azadbakht L; Rezaei N; Chamari M; Shabani S; Mahmoudi M
    Clin Nutr ESPEN; 2022 Apr; 48():87-98. PubMed ID: 35331539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial.
    Properzi C; O'Sullivan TA; Sherriff JL; Ching HL; Jeffrey GP; Buckley RF; Tibballs J; MacQuillan GC; Garas G; Adams LA
    Hepatology; 2018 Nov; 68(5):1741-1754. PubMed ID: 29729189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diets with high or low protein content and glycemic index for weight-loss maintenance.
    Larsen TM; Dalskov SM; van Baak M; Jebb SA; Papadaki A; Pfeiffer AF; Martinez JA; Handjieva-Darlenska T; Kunešová M; Pihlsgård M; Stender S; Holst C; Saris WH; Astrup A;
    N Engl J Med; 2010 Nov; 363(22):2102-13. PubMed ID: 21105792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial.
    Rein M; Ben-Yacov O; Godneva A; Shilo S; Zmora N; Kolobkov D; Cohen-Dolev N; Wolf BC; Kosower N; Lotan-Pompan M; Weinberger A; Halpern Z; Zelber-Sagi S; Elinav E; Segal E
    BMC Med; 2022 Feb; 20(1):56. PubMed ID: 35135549
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.